US10144755B2ActiveUtilityA1

Substituted nucleosides, nucleotides and analogs thereof

96
Assignee: ALIOS BIOPHARMA INCPriority: Dec 21, 2012Filed: Sep 2, 2016Granted: Dec 4, 2018
Est. expiryDec 21, 2032(~6.4 yrs left)· nominal 20-yr term from priority
Inventors:Leonid BeigelmanGuangyi WangDavid Bernard Smith
C07H 19/16C07H 19/10C07H 19/207C07H 19/213A61P 31/14C07H 19/20C07H 19/06C07H 19/173A61K 31/7076A61P 31/20
96
PatentIndex Score
10
Cited by
279
References
3
Claims

Abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A compound selected from the group consisting of: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt of the foregoing. 
       
     
     
       2. A compound selected from the group consisting of: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt of the foregoing. 
       
     
     
       3. A compound selected from the group consisting of: 
       
         
           
           
               
               
           
         
         or a pharmaceutically acceptable salt of the foregoing.

Join the waitlist — get patent alerts

Track US10144755B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.